Literature DB >> 6221809

Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.

A Kono, Y Hara, S Sugata, Y Karube, Y Matsushima, H Ishitsuka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6221809     DOI： 10.1248/cpb.31.175

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  21 in total

Review 1.  The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.

Authors:  H A Bardelmeijer; O van Tellingen; J H Schellens; J H Beijnen
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

2.  Impact of the new AJCC staging system and adjuvant treatment in rectal cancer.

Authors:  Shin Ae Lee; Hyuk-Chan Kwon; Min Ah Park; Chang Kil Jung; Sung-Hyun Kim; Ki-Jae Park; Hong-Jo Choi; Hyung-Sik Lee; Mee Sook Roh; Jae-Seok Kim; Hyo-Jin Kim
Journal:  Cancer Res Treat       Date:  2004-04-30       Impact factor: 4.679

3.  Unresectable gastric cancer with multiple liver metastases effectively treated with combined paclitaxel and doxifluridine chemotherapy.

Authors:  Shin Mizutani; Tsukasa Oyama; Nobutaka Hatanaka; Fumihiro Uchikoshi; Katsuhide Yoshidome; Masayuki Tori; Shigeyuki Ueshima; Masaaki Nakahara; Kazuyasu Nakao
Journal:  Int J Clin Oncol       Date:  2006-12-25       Impact factor: 3.402

4.  Pharmacokinetic study of doxifluridine given by 5-day stepped-dose infusion.

Authors:  P A Reece; I N Olver; R G Morris; J F Bishop; T W Guentert; H S Hill; B L Hillcoat
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 5.  Capecitabine: preclinical pharmacology studies.

Authors:  H Ishitsuka
Journal:  Invest New Drugs       Date:  2000-11       Impact factor: 3.850

6.  Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer.

Authors:  A Jimeno; C Grávalos; P Escudero; I Sevilla; M E Vega-Villegas; V Alonso; I Juez; R García-Carbonero; H Bovio; R Colomer; H Cortés-Funes
Journal:  Clin Transl Oncol       Date:  2008-01       Impact factor: 3.405

7.  Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine.

Authors:  H Eda; K Fujimoto; S Watanabe; M Ura; A Hino; Y Tanaka; K Wada; H Ishitsuka
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 8.  Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.

Authors:  N S Brown; R Bicknell
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

9.  Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression levels in tumor and normal tissue specimens of T3 human colorectal carcinoma.

Authors:  Atsushi Okita; Kazunori Tsukuda; Masakazu Murakami; Tetsuya Ota; Hiroyoshi Doihara; Manabu Suda; Tomoharu Nakano; Kinya Matsuoka; Eiji Suzuki; Minoru Naito; Akio Andou; Nobuyoshi Shimizu
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

10.  Effect of age on the disposition and tissue clearances of fluorinated pyrimidines in rats.

Authors:  J L Au
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.